{
    "b95b7438-ec16-4d4d-826d-5891e7982b36": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00766532",
        "Secondary_id": "NCT01468675",
        "Statement": "There are no cases of anorexia, hypothermia or hallucinations recorded in the Aes of the primary trial or the secondary trial.",
        "Label": "Entailment"
    },
    "4ed1c5fd-58e5-4fe8-97b1-59ed509ccb10": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01702571",
        "Statement": "there are several different instances of cardiac related AE recorded for cohort 1 of the primary trial",
        "Label": "Entailment"
    },
    "6d0812b9-f9bd-4cd6-82aa-9c272eba23be": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01306032",
        "Secondary_id": "NCT01614210",
        "Statement": "Patients in the primary trial and the secondary trial  suffered Thromboembolic events.",
        "Label": "Contradiction"
    },
    "571d4650-e64b-4cb2-b719-0d7064e51745": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01498458",
        "Statement": "in the primary trial there were 10 times the number of Hepatotoxicity cases as there were cases of hypertension and Pancreatectomy",
        "Label": "Contradiction"
    },
    "d7abbd7d-a767-49c0-bc99-1c28074eac21": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02336737",
        "Statement": "Cohort 1 of the primary trial did not report any Aes, however almost all of cohort 2 candidates suffered at least one ae",
        "Label": "Contradiction"
    },
    "412583db-ce19-451d-a804-3837e4dcaea3": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00587964",
        "Statement": "Coronary artery stenosis are the most common AE recorded in the primary trial",
        "Label": "Contradiction"
    },
    "dc60304d-6fd2-4b12-9108-b5ce78454d42": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00686127",
        "Secondary_id": "NCT00075764",
        "Statement": "There are less total adverse events in the primary trial than in the secondary trial, but more cases of Cardiac-ischemia/infarction in the primary trial than in the secondary trial",
        "Label": "Contradiction"
    },
    "a72ddea5-ee4b-4895-bd8c-10b4a143c3f8": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01803282",
        "Secondary_id": "NCT00963911",
        "Statement": "0/7 the primary trial participants, and 0/1674 the secondary trial participants suffered an AE.",
        "Label": "Entailment"
    },
    "23f84ae0-fd01-4799-8872-118e22a015e8": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00706030",
        "Statement": "Only three different types of adverse events affected patients in the primary trial, Pancreatitis, Cholelithiasis, Hepatic pain and Febrile neutropenia",
        "Label": "Contradiction"
    },
    "c2aea351-6ce5-4d26-9ba5-2632c6367b93": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01127763",
        "Statement": "at least one patient in the primary trial suffered several different adverse events",
        "Label": "Entailment"
    },
    "5af6aa8c-69f5-44a5-9c7c-6c94a0fda6e8": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00404066",
        "Secondary_id": "NCT01111825",
        "Statement": "The only types of Aes observed in patients from the secondary trial were Eyelid oedema, Upper gastrointestinal haemorrhage and Chest pain, no aes wererecorded in the primary trial",
        "Label": "Contradiction"
    },
    "e530eed4-ee8b-4a7f-bb36-5ce9ea7ddebe": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01803282",
        "Secondary_id": "NCT00963911",
        "Statement": "2/73 the primary trial participants, and 0/1674 the secondary trial participants suffered an Acute myocardial infarction ",
        "Label": "Contradiction"
    },
    "dd3d2183-d062-41ed-af63-ae475f2246ec": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00775645",
        "Secondary_id": "NCT02002533",
        "Statement": "In both the primary trial and the secondary trial there were several adverse events which occurred in more than 30% of participants.",
        "Label": "Contradiction"
    },
    "711fdd40-52ec-401c-90fc-5a11de547ab6": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01629615",
        "Statement": "eating disorders were not common for the primary trial candidates",
        "Label": "Entailment"
    },
    "43989f85-a059-4dc7-a805-16e081706b2f": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02002533",
        "Secondary_id": "NCT02734979",
        "Statement": "the primary trial and the secondary trial have 0 recorded adverse events.",
        "Label": "Entailment"
    },
    "282a33db-aed6-4daa-bea6-299f424914bb": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00182793",
        "Secondary_id": "NCT00632489",
        "Statement": "over 15% of patients in the primary trial and the secondary trial suffered from infections during the study period",
        "Label": "Contradiction"
    },
    "a0c1da21-1e1f-493b-81e9-4ef133c20090": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01286168",
        "Secondary_id": "NCT01419717",
        "Statement": "The most common adverse event in the secondary trial was Anaemia, affecting more than 5% of patients, there were no recorded AEs in the primary trial.",
        "Label": "Contradiction"
    },
    "217b0362-9dd0-4f10-8ca5-c097688bb738": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01664091",
        "Secondary_id": "NCT01383174",
        "Statement": "There were more cases of Infection, Asymmetry and nausea in the primary trial than in the secondary trial.",
        "Label": "Contradiction"
    },
    "cca11232-84c4-44e1-89f1-b57b28643dce": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT03015649",
        "Secondary_id": "NCT00583700",
        "Statement": "the primary trial and the secondary trial recorded over 100 total adverse events in their cohorts.",
        "Label": "Contradiction"
    },
    "32cc173a-b271-47c9-997d-df17ce1c7494": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01048099",
        "Statement": "None of the individual adverse event types recorded in the primary trial affected more than one patient",
        "Label": "Contradiction"
    },
    "cfa6601b-af52-4eee-883c-89d42b73e02b": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT03557801",
        "Secondary_id": "NCT00432562",
        "Statement": "the secondary trial patients suffered from anemia, pneumonia and stupor more often than patients in the primary trial.",
        "Label": "Entailment"
    },
    "f58fda4c-f4fd-44a7-8a0f-5d3a16929709": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02504424",
        "Statement": "one patient in the primary trial had an incident where a surgical incision reopened after the surgery.",
        "Label": "Entailment"
    },
    "7b9338a5-d3a8-405f-a197-736caf32c455": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02187783",
        "Secondary_id": "NCT01222390",
        "Statement": "More Palpitations, Pericardial effusions and Abdominal pains were recorded in cohort 2 of the primary trial than in cohort 1 of the secondary trial.",
        "Label": "Contradiction"
    },
    "8f078a17-14cd-4bbc-a9b6-b377ffa077b5": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00143390",
        "Statement": "There was at least 1 recorded gastro-intestinal adverse event and 2 or more psychiatric events in the primary trial",
        "Label": "Contradiction"
    },
    "6e1489a6-3a42-4b52-b690-fb1dd8892749": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01390818",
        "Statement": "The all recorded Aes in the primary trial occurred to cohort 1 patients",
        "Label": "Entailment"
    },
    "de6b5ea7-b593-43b7-8fe0-358991878e86": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01306032",
        "Secondary_id": "NCT01614210",
        "Statement": "Patients in the primary trial do not suffer any of the same adverse events as patients in the secondary trial.",
        "Label": "Entailment"
    },
    "827af363-cfd3-4233-9029-e8c7e053c661": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02796755",
        "Secondary_id": "NCT00756496",
        "Statement": "There were more adverse events observed in the secondary trial than in the primary trial.",
        "Label": "Contradiction"
    },
    "98b04dac-b155-4afd-8855-03ed818df5d9": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00992602",
        "Secondary_id": "NCT00357734",
        "Statement": "We cannot compare the adverse events in the primary trial and the secondary trial, as they do not appear to have been recorded for the primary trial.",
        "Label": "Entailment"
    },
    "8f4d4e78-5e46-47b6-865c-ad6b689d69e0": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00795769",
        "Secondary_id": "NCT00408681",
        "Statement": "Far more patients in the secondary trial were recorded to have experienced Chest Pain, than patients in the primary trial.",
        "Label": "Contradiction"
    },
    "d53cf5fe-1104-4b05-886c-bb5499cdc047": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00088413",
        "Secondary_id": "NCT01989546",
        "Statement": "All of the adverse events recorded in the primary trial were related to the musculoskeletal system this is not the case for the secondary trial.",
        "Label": "Contradiction"
    },
    "a5415a49-0b04-4f8f-a7ec-a8c276b2cf64": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02403271",
        "Secondary_id": "NCT01649271",
        "Statement": "There are more cases of Biliary colic and Diarrhoea in the secondary trial than in the primary trial.",
        "Label": "Entailment"
    },
    "c12d4dba-17b9-45d6-9a3f-75be190b7795": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT03015649",
        "Secondary_id": "NCT00583700",
        "Statement": "the primary trial and the secondary trial recorded the same number of adverse events in their cohorts.",
        "Label": "Entailment"
    },
    "7f6d7fd9-8aed-472d-af54-b288d16c2135": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01013740",
        "Secondary_id": "NCT00978250",
        "Statement": "Several patients in the secondary trial and the primary trial suffered from Tumour lysis syndrome",
        "Label": "Contradiction"
    },
    "49c63fc5-be4b-4474-8bfc-0ddf9cf438db": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00992602",
        "Secondary_id": "NCT00357734",
        "Statement": "There are more cases of Bronchopneumonia and General physical health deterioration in the primary trial than in the secondary trial.",
        "Label": "Contradiction"
    },
    "8367e2fc-f384-43c0-af4e-d4ec41281b2e": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01617668",
        "Statement": "Most patients in cohort 1 of the primary trial suffered adverse events, the inverse is true in cohort 2.",
        "Label": "Contradiction"
    },
    "20493bc1-bda8-4255-a1d4-40cb499bd845": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00182793",
        "Secondary_id": "NCT00632489",
        "Statement": "There was at least 1 case of infection in both the primary trial and the secondary trial",
        "Label": "Entailment"
    },
    "93eef0e8-7a40-452a-a61e-a9d671dcacbd": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00687102",
        "Secondary_id": "NCT00819182",
        "Statement": "There are no Intestinal obstructions or incidents of Pancytopenia observed in the patient cohorts of the primary trial and the secondary trial",
        "Label": "Entailment"
    },
    "3d9a7121-da16-4e7b-a02d-1932f46cbb77": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT03557801",
        "Secondary_id": "NCT00432562",
        "Statement": "the secondary trial patients suffered from anemia, pneumonia and stupor more often than patients in the primary trial, but more cases of FEBRILE INFECTIONs were recorded in the primary trial.",
        "Label": "Contradiction"
    },
    "5e5253e5-fd72-4f2b-84ba-b370545cd182": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01606748",
        "Statement": "several cases of Anaemia and Febrile neutropenia were recorded in cohort 1 of the primary trial, but 0 cases of Pancytopenia.",
        "Label": "Contradiction"
    },
    "d71c6377-89da-457d-acbc-827be4ddb8e5": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01855828",
        "Statement": "There was one psychiatric adverse event in the primary trial, which affected less than 10% of patients",
        "Label": "Entailment"
    },
    "74aebfd6-c201-4c6f-a7af-7e4e0de6b661": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01286168",
        "Secondary_id": "NCT01419717",
        "Statement": "The most common adverse event in the secondary trial was Anaemia, there were no recorded AEs in the primary trial.",
        "Label": "Entailment"
    },
    "886a066c-520e-4454-bf20-43ad24b6baf9": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00795769",
        "Secondary_id": "NCT00408681",
        "Statement": "Far more patients in the secondary trial were recorded to have experienced Aes, than patients in the primary trial.",
        "Label": "Entailment"
    },
    "fdadf425-1eaf-4e63-b034-29afcbe48baf": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01008904",
        "Statement": "The only AE recorded in the primary trial was Stomatitis.",
        "Label": "Contradiction"
    },
    "3ad9820f-4ef2-4624-b08a-b910adf25836": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00428220",
        "Secondary_id": "NCT03092934",
        "Statement": "Ascites was more common for patients in the primary trial, and Pneumocystis jirovecii pneumonia was more common in the secondary trial.",
        "Label": "Entailment"
    },
    "593bde37-5962-441b-ac10-dbe3120cec99": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01252290",
        "Statement": "less than 5% of patients in the primary trial suffered Aes",
        "Label": "Contradiction"
    },
    "7270c176-7bf2-4b0d-941d-912f5a3ed62c": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00262834",
        "Secondary_id": "NCT00820872",
        "Statement": "0 adverse events were observed in the primary trial, and none of the adverse events in the secondary trial affected more than 30% of patients.",
        "Label": "Entailment"
    },
    "67f1754a-420c-4605-a41d-784c4d1e77b0": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01649271",
        "Secondary_id": "NCT02165839",
        "Statement": "there was a total of 3 cases of shingles across both the patient cohorts of the primary trial and the secondary trial.",
        "Label": "Contradiction"
    },
    "7482499c-6836-4f68-83f4-4af09b14d566": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00656305",
        "Statement": "There were no deaths or Hospitalizations in cohort 2 of the primary trial",
        "Label": "Entailment"
    },
    "d11356c5-cf48-40dc-aa23-46e71f564afd": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00686127",
        "Secondary_id": "NCT00075764",
        "Statement": "There are less total adverse events and less types of adverse events recorded in the primary trial than in the secondary trial.",
        "Label": "Entailment"
    },
    "1cda1a1d-3ca1-4838-9054-bcab763bb5d0": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01702571",
        "Statement": "All of the Aes recorded for cohort 1 of the primary trial are related to mental health",
        "Label": "Contradiction"
    },
    "1af4d0ac-d0f2-402a-8bdb-0e10c0823b0f": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00317603",
        "Secondary_id": "NCT00293540",
        "Statement": "The most commonly occuring adverse event across the patient cohorts of the primary trial and the secondary trial was Syncope, which occurred in 25.00% of the primary trial patients.",
        "Label": "Contradiction"
    },
    "837329c4-d046-4997-ad41-f230d3db7255": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01246973",
        "Secondary_id": "NCT01091974",
        "Statement": "There were no cardiac or psychiatric Aes recorded during the primary trial and the secondary trial.",
        "Label": "Entailment"
    },
    "cbba3546-5b88-42d0-882d-024d5f267d97": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02187783",
        "Secondary_id": "NCT01222390",
        "Statement": "More Palpitations, Pericardial effusions and Abdominal pains were recorded in the primary trial than in the secondary trial.",
        "Label": "Entailment"
    },
    "fdd9ccc8-95c0-48d9-bc4d-3ef7469dbb9a": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01781299",
        "Secondary_id": "NCT02413008",
        "Statement": "There are no unexpected deaths or Hospitalizations that occurred in the primary trial or the secondary trial, the only AEs recorded were 3 cases of Lymphoma.",
        "Label": "Contradiction"
    },
    "3a0c092c-7e18-4108-ae66-552f7069831f": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01011218",
        "Secondary_id": "NCT00775645",
        "Statement": "Across both the primary trial and the secondary trial over 10 deaths were recorded in the adverse events.",
        "Label": "Contradiction"
    },
    "c94158fd-10f5-4142-a361-5b346ff2c295": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02403271",
        "Secondary_id": "NCT01649271",
        "Statement": "There are more cases of Biliary colic and Clostridium difficile colitis in the secondary trial than in the primary trial.",
        "Label": "Contradiction"
    },
    "494a4094-5a05-4c7d-b7a7-60baeb210e5a": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01781299",
        "Secondary_id": "NCT02413008",
        "Statement": "There are no unexpected deaths or Hospitalizations that occurred in the primary trial or the secondary trial",
        "Label": "Entailment"
    },
    "6920329b-7559-415e-9346-c06909526421": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00756717",
        "Secondary_id": "NCT01252290",
        "Statement": "There were 0 cases of Febrile neutropenia or Cholelithiasis in the primary trial and the secondary trial",
        "Label": "Entailment"
    },
    "0c73bdd4-7244-433c-8b5e-bf335f21701c": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01855828",
        "Statement": "There were severalpsychiatric adverse event in the primary trial, including an eating disorder and Schizophrenia",
        "Label": "Contradiction"
    },
    "06b8d395-0fe7-4206-b118-5e478779cce0": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00256217",
        "Secondary_id": "NCT00182767",
        "Statement": "There were no patients in the primary trial or the secondary trial that suffered at less than 3 different AEs.",
        "Label": "Contradiction"
    },
    "68f673a5-6ddf-487a-ad88-4903d92e1746": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00256217",
        "Secondary_id": "NCT00182767",
        "Statement": "There were no patients with recorded Aes in the primary trial, whereas every patient in the secondary trial suffered at least one adverse event.",
        "Label": "Entailment"
    },
    "102bbdcd-14ea-4dd5-a0bb-4cea343bb6ed": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01434342",
        "Secondary_id": "NCT02599194",
        "Statement": "There were more cases of Mucositis Oral, Bladder Infection and Thromboembolic events recorded in the primary trial than in the secondary trial",
        "Label": "Entailment"
    },
    "fa586070-5821-4a70-9812-9d7c6e5df330": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01127763",
        "Statement": "5 patients in the primary trial suffered 3 or more adverse events",
        "Label": "Contradiction"
    },
    "4493c1ed-668a-44d4-9b3e-767f597d4fa8": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00687102",
        "Secondary_id": "NCT00819182",
        "Statement": "There are 3 total cases of Asthenia and 5 total cases of Pyrexia recorded in the patient cohorts of the primary trial and the secondary trial",
        "Label": "Contradiction"
    },
    "a1a3cda8-7324-4270-aaf9-51ad1b40be07": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02115607",
        "Secondary_id": "NCT00372424",
        "Statement": "the secondary trial recorded 11 more Aes than the primary trial",
        "Label": "Entailment"
    },
    "bc7b62ad-797e-419e-b5f9-888117aedf6b": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00766532",
        "Secondary_id": "NCT01468675",
        "Statement": "There are several cases of swelling, hypothermia and confusion recorded in the Aes of the primary trial and the secondary trial.",
        "Label": "Contradiction"
    },
    "2bf9e0d9-1195-4c03-b2bc-d491ff1cd174": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01967823",
        "Statement": "36.36% of the primary trial patients suffered an increase in Blood bilirubin.",
        "Label": "Contradiction"
    },
    "1bf99d45-84a7-41cb-8263-d1ccb489bc66": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00404066",
        "Secondary_id": "NCT01111825",
        "Statement": "The only types of Aes observed in patients from the secondary trial were Eyelid oedema and Chest pain, no aes wererecorded in the primary trial",
        "Label": "Entailment"
    },
    "25cbaa44-4715-417b-9bd0-12fef06053b8": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01252290",
        "Statement": "less than 10 patients in the primary trial suffered Aes",
        "Label": "Entailment"
    },
    "fbde81ad-0d06-4d2a-8baa-eb5eace1b3ec": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02796755",
        "Secondary_id": "NCT00756496",
        "Statement": "the primary trial and the secondary trial do not have any recorded adverse events for their participants.",
        "Label": "Entailment"
    },
    "5e6797ef-370c-4b35-9e1d-37e694b538a6": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00623831",
        "Statement": "25% of patients in the primary trial suffer Increased pleural effusion and Rapid disease progression  ",
        "Label": "Contradiction"
    },
    "44412911-1f34-4841-a795-86eed5a209d7": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT03384316",
        "Statement": "All Infections and Fever cases in the primary trial were for patients in cohort 1.",
        "Label": "Contradiction"
    },
    "d118efb5-ea31-49ca-8e20-686c85081e94": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00820872",
        "Secondary_id": "NCT00706030",
        "Statement": "Cholelithiasis was twice as common for the primary trial participants than the secondary trial participants",
        "Label": "Contradiction"
    },
    "aefb2cc5-3101-416b-bae4-c9a1e7d8f39e": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00408681",
        "Secondary_id": "NCT02178722",
        "Statement": "Recurrent malignancies, Graft-versus-host disease, Infection, Altered mental status and Diffuse alveolar hemorrhage were all more commonly seen in the adverse events of the primary trial than in the secondary trial.",
        "Label": "Entailment"
    },
    "f45b251f-2fec-44b7-8fc0-dd0d06a44d3b": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00775645",
        "Secondary_id": "NCT02002533",
        "Statement": "In both the primary trial and the secondary trial there were 0 adverse events which occurred in more than 1% of participants.",
        "Label": "Entailment"
    },
    "9d94e597-591d-409e-a8e2-b205a83533a5": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01498458",
        "Statement": "in the primary trial there were 3 times the number of Hepatotoxicity cases as there were cases of hypertension and Pancreatectomy",
        "Label": "Entailment"
    },
    "90cecb95-9f89-4747-81c3-96545edaf3f4": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01466972",
        "Statement": "No two patients in the primary trial suffered the same type of adverse event.",
        "Label": "Entailment"
    },
    "c41ed5cf-4629-4a4f-b564-197d705ec9cc": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00756717",
        "Secondary_id": "NCT01252290",
        "Statement": "There were 0 adverse events in the primary trial and the secondary trial",
        "Label": "Contradiction"
    },
    "956a23c9-f76f-4492-9f00-acdbaf6ac083": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00088413",
        "Secondary_id": "NCT01989546",
        "Statement": "The majority of the adverse events recorded in the primary trial were blood and bone marrow related, this is not the case for the secondary trial.",
        "Label": "Entailment"
    },
    "bc50160f-7490-4c30-b373-9474707b02b3": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00262834",
        "Secondary_id": "NCT00820872",
        "Statement": "0 adverse events were observed in the primary trial, and none of the adverse events in the secondary trial affected more than 30% of patients, apart from Skin infections",
        "Label": "Contradiction"
    },
    "ff11f88f-a4cb-481e-bf56-afa5c0adda19": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02239601",
        "Secondary_id": "NCT01537029",
        "Statement": "the secondary trial recorded slightly more total adverse events in its patient cohorts than the primary trial.",
        "Label": "Contradiction"
    },
    "29bed237-ccbb-460b-a50b-fbdc9e52fdd1": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01967823",
        "Statement": "All AE types in the primary trial affected less than 10% of patients",
        "Label": "Entailment"
    },
    "88951a9e-179e-4284-9f98-141eb3d76369": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02599194",
        "Secondary_id": "NCT02312934",
        "Statement": "Aes were not recorded for the primary trial or the secondary trial.",
        "Label": "Entailment"
    },
    "71698d59-3bbe-4e8f-85c8-bf2110727155": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00706030",
        "Statement": "Only 4 different types of adverse events affected patients in the primary trial, all of which were in cohort 2",
        "Label": "Entailment"
    },
    "b88356ec-038f-4f5c-bf14-750059dbba4f": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00317603",
        "Secondary_id": "NCT00293540",
        "Statement": "The most commonly occuring adverse event across the patient cohorts of the primary trial and the secondary trial was Syncope",
        "Label": "Entailment"
    },
    "d9d506ef-20ed-44e2-9809-07cb0772535b": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT03384316",
        "Statement": "All Infections and Infestations cases in the primary trial were for patients in cohort 1.",
        "Label": "Entailment"
    },
    "fac10570-e1ed-4b0a-b847-55eb25265d25": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01606748",
        "Statement": "1 case of Anaemia and Febrile neutropenia were recorded in cohort 1 of the primary trial, but no cases of Pancytopenia.",
        "Label": "Entailment"
    },
    "228308ea-2483-4311-a975-ca974ff797c6": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02504424",
        "Statement": "Nobody taking part in the primary trial suffered a UTI",
        "Label": "Contradiction"
    },
    "ef2af81d-e19c-49c9-8ff0-309b87eb6f38": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01008904",
        "Statement": "the primary trial only has a single adverse event recorded for its patient cohort.",
        "Label": "Entailment"
    },
    "f7de4d97-31e4-48e0-ab1a-1e3d8a152e8b": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00454532",
        "Secondary_id": "NCT01301729",
        "Statement": "Most patients in the secondary trial and the primary trial did not suffer any adverse events",
        "Label": "Entailment"
    },
    "8d685159-80a2-4b2c-8ca3-066d03e1cf66": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01434342",
        "Secondary_id": "NCT02599194",
        "Statement": "There were more cases of Mucositis Oral, epileptic seizures and Thromboembolic events recorded in the primary trial than in the secondary trial",
        "Label": "Contradiction"
    },
    "9562c377-c748-46d7-a5f2-eb492d20e477": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01086605",
        "Statement": "there were 0 cases of Hypertension, Dehydration and Dyspnea in either cohort of the primary trial",
        "Label": "Entailment"
    },
    "c5ece9f7-9119-4fa2-b60d-f2f15c68ae02": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00408681",
        "Secondary_id": "NCT02178722",
        "Statement": "Recurrent malignancies, Graft-versus-host disease, Anaemia, Cardiac failure and Diffuse alveolar hemorrhage were all more commonly seen in the adverse events of the primary trial than in the secondary trial.",
        "Label": "Contradiction"
    },
    "8f8be6b6-df75-4757-bc64-b2fbc8849f70": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01649271",
        "Secondary_id": "NCT02165839",
        "Statement": "There was one case of shingles recorded in group 2 of the secondary trial, but no cases in group 1 of the secondary trial and the primary trial.",
        "Label": "Entailment"
    },
    "520f44e8-b74b-44a6-a7cf-496275847af1": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT03346161",
        "Statement": "Both cohorts of the primary trial recorded 0 Aes",
        "Label": "Entailment"
    },
    "0c902de2-30b5-4ab8-9739-70be987d043a": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00623831",
        "Statement": "25% of cohort 2 patients in the primary trial suffer Increased pleural effusion",
        "Label": "Entailment"
    },
    "d1d5671f-79dd-4fd3-a4aa-b5f81d8a944f": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT03346161",
        "Statement": "there were 4 more patients that suffered adverse events in cohort 1 of the primary trial than in cohort 2 of the primary trial ",
        "Label": "Contradiction"
    },
    "fabf3f7a-48df-4940-93e2-8cbe976c4246": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01086605",
        "Statement": "there were 0 cases of Hypertension, Edema and Dyspnea in either cohort of the primary trial",
        "Label": "Contradiction"
    },
    "e8351b8b-d707-4766-b875-777557f0653f": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00428220",
        "Secondary_id": "NCT03092934",
        "Statement": "Pericardial effusions were more common for patients in the primary trial, and Corneal deposits were more common in the secondary trial.",
        "Label": "Contradiction"
    },
    "05530068-7a95-46f6-88d2-84e53ee2ff35": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00587964",
        "Statement": "General symptoms are the most common AE recorded in the primary trial",
        "Label": "Entailment"
    },
    "2cde3c46-f21a-4177-afc8-94f851854b98": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00143390",
        "Statement": "There was at least 1 recorded gastro-intestinal adverse event in the primary trial",
        "Label": "Entailment"
    },
    "6d7c7740-c399-4d73-82c8-2ef0d4739341": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02336737",
        "Statement": "Cohort 1 of the primary trial did not report any Aes",
        "Label": "Entailment"
    },
    "fe6baecc-71eb-4b15-ba15-66d57539c702": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01920061",
        "Statement": "The same perecentage of patients suffered adverse events in both cohorts of the primary trial",
        "Label": "Contradiction"
    },
    "f9e4988c-a325-40bc-8220-e7d0c404fd37": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01048099",
        "Statement": "None of the individual adverse event types recorded in the primary trial affected more than a quarter of the patient cohort",
        "Label": "Entailment"
    },
    "ce40b0b9-d8d4-45f4-a2dc-4adb8e7103ac": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01617668",
        "Statement": "More patients in cohort 1 of the primary trial suffered adverse events than in cohort 2.",
        "Label": "Entailment"
    },
    "ad5ca7e8-3e5d-43b8-9618-99f56fc70290": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01246973",
        "Secondary_id": "NCT01091974",
        "Statement": "There were no cardiac or phsyciatric Aes recorded during the primary trial and the secondary trial, however several other types of Aes were observed.",
        "Label": "Contradiction"
    },
    "620b6390-df07-45fe-9ef9-55a32521c740": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00820872",
        "Secondary_id": "NCT00706030",
        "Statement": "Diarrhoea was more common for the primary trial participants than the secondary trial participants",
        "Label": "Entailment"
    },
    "e6bba244-c154-4143-a5f2-5f8b1c304a97": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02599194",
        "Secondary_id": "NCT02312934",
        "Statement": " Suspected Serious Adverse reactions were more common in the adverse events section of the primary trial than in the secondary trial.",
        "Label": "Contradiction"
    },
    "a5657dcd-1ee5-44f6-bb21-e718259c4b2e": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00656305",
        "Statement": "There were no deaths or Hospitalizations in cohort 2 of the primary trial, and only a single case of Atrial fibrillation .",
        "Label": "Contradiction"
    },
    "4bc60955-6137-4496-b780-5fb8e90dc3ed": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01466972",
        "Statement": "maculo-papular Rash was a common adverse event for the primary trial participants.",
        "Label": "Contradiction"
    },
    "73feb437-66f3-44fd-8d9c-ab3204e6eac3": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01390818",
        "Statement": "Several recorded Aes in the primary trial occurred to cohort 1 patients",
        "Label": "Contradiction"
    },
    "f8dbd18d-2b55-4f0f-92a7-db3b1ecc3b6d": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02239601",
        "Secondary_id": "NCT01537029",
        "Statement": "the primary trial and the secondary trial recorded the same total number of adverse events in their patient cohorts.",
        "Label": "Entailment"
    },
    "1cb125fb-0be1-49c6-b68b-64b525278c9c": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01011218",
        "Secondary_id": "NCT00775645",
        "Statement": "Across both the primary trial and the secondary trial only one death was recorded in the adverse events.",
        "Label": "Entailment"
    },
    "73981f59-887e-4778-a78a-0bf7b7a405b7": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02002533",
        "Secondary_id": "NCT02734979",
        "Statement": "the primary trial has 4 more adverse events recorded than the secondary trial",
        "Label": "Contradiction"
    },
    "e53898b8-422f-4317-b2f6-c487409b0750": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01013740",
        "Secondary_id": "NCT00978250",
        "Statement": "In total there are less cases of anemia in the primary trial than in the secondary trial.",
        "Label": "Entailment"
    },
    "7b819ac1-92e6-41ce-881c-0f4581a690ee": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01664091",
        "Secondary_id": "NCT01383174",
        "Statement": "There were more cases of Infection, Asymmetry and Deflation in the primary trial than in the secondary trial.",
        "Label": "Entailment"
    },
    "c09c08d5-189f-4e15-acb8-2c3cb235aaa6": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01920061",
        "Statement": "The same number of Aes were reported for both cohorts in the primary trial",
        "Label": "Entailment"
    },
    "c39ec45a-1664-49aa-8356-abbecf045001": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT00454532",
        "Secondary_id": "NCT01301729",
        "Statement": "over 97% of patients in the secondary trial and the primary trial did not suffer any adverse events",
        "Label": "Contradiction"
    },
    "c43583e4-da5f-42b3-ad3d-7ba8b6b28f2b": {
        "Type": "Comparison",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT02115607",
        "Secondary_id": "NCT00372424",
        "Statement": "the secondary trial recorded 11 more cases of Intestinal perforation than the primary trial",
        "Label": "Contradiction"
    },
    "070ba2da-932a-4a62-861e-3f2c89630b4d": {
        "Type": "Single",
        "Section_id": "Adverse Events",
        "Primary_id": "NCT01629615",
        "Statement": "Most the primary trial candidates suffered from some kind of eating disorder during the study duration",
        "Label": "Contradiction"
    }
}